• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Effect of Enzymatic Degradation On the Mechanical Properties of Biologic Scaffold Materials

Effect of Enzymatic Degradation On the Mechanical Properties of Biologic Scaffold Materials

Afua H Annor, BS, Michael E Tang, BS, Chi Lun Pui, BS, Gregory C Ebersole, MS MS, Margaret M Frisella, RN, Brent D Matthews, MD, Corey R Deeken, PhD. Washington University in St. Louis

 

 INTRODUCTION: In the body, biologic scaffolds are exposed to matrix metalloproteinases (MMPs) which are produced by inflammatory cells (neutrophils). Scaffolds must resist enzymatic degradation and support cellular attachment, neotissue deposition, and angiogenesis. The purpose of this study was to evaluate the effects of enzymatic degradation on the mechanical properties of biologic scaffold materials.

METHODS: Nine materials were evaluated (4 porcine dermis – PermacolTM, CollaMendTM, StratticeTM, XenMatrixTM; 2 human dermis – AlloMaxTM, FlexHD®; 2 bovine pericardium – Veritas®, PeriGuard®; and 1 porcine small intestine submucosa – SurgisisTM). Sixty (n=60) specimens were prepared of each. Ten specimens (n=10) were hydrated in saline at 37°C and subjected to uniaxial tension at a rate of 300mm/min until failure to establish the baseline “0 hour” properties before exposure to collagenase. The other fifty specimens (n=50) were incubated in a collagenase solution at 37°C for 2, 6, 12, 24, or 30 hours (n=10 each group). Specimens were then subjected to uniaxial tensile testing at a rate of 300mm/min until failure. A one-way analysis of variance (ANOVA) was performed, followed by a Fisher’s LSD post-test as appropriate. Statistical significance was set at the p<0.05 level.

RESULTS: Tensile strength was significantly reduced after 30 hours of exposure to collagenase for CollaMendTM, AlloMaxTM, Veritas®, StratticeTM, XenMatrixTM, PermacolTM, and FlexHD® (p<0.01), while PeriGuard® demonstrated a slight increase in tensile strength (p=0.0188). Differences were also observed between crosslinked and non-crosslinked scaffolds of the same tissue type. For instance, crosslinked bovine pericardium (PeriGuard®) maintained greater tensile strength than non-crosslinked bovine pericardium (Veritas®) throughout all exposure periods (p<0.0001). Similarly, crosslinked porcine dermis (PermacolTM) maintained greater tensile strength than non-crosslinked porcine dermis (StratticeTM and XenMatrixTM) throughout all exposure periods (p<0.0001).

Some scaffolds did not survive the longer incubation periods and were so degraded that mechanical testing was not possible. Specimens were measurable for PermacolTM, CollaMendTM, StratticeTM, FlexHD®, and PeriGuard® scaffolds throughout all exposure periods up to 30 hours. However, specimens of SurgisisTM and Veritas® were only measurable up to the 6 hour exposure period, and specimens of XenMatrixTM and AlloMaxTM were only measurable up to the 12 hour exposure period.

CONCLUSIONS: Materials that deteriorate rapidly after in vitro enzymatic exposure may be at risk for rapid in vivo degradation and loss of strength when exposed to a wound environment with elevated levels of MMPs.


Session Number: SS01 – Basic Science
Program Number: S001

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search